ABIONYX Pharma SA Balance Sheet
ABIONYX Pharma SA's total assets for Q4 2025 were €12.86M, a decrease of -0.88% from the previous quarter. FR:ABNX total liabilities were €8.60M for the fiscal quarter, a 13.74% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.